JAMES KNOX: Open Payments
NPI 1063679173 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 33 payments from 9 companies in 2025. Trend: 2023 $439 · 2024 $583 · 2025 $1,143
Food & beverage: $1,031Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $407 |
| Alkermes, Inc. | 6 | $202 |
| E.R. Squibb & Sons, L.L.C. | 3 | $165 |
| Teva Pharmaceuticals USA, Inc. | 6 | $150 |
| Otsuka America Pharmaceutical, Inc. | 5 | $87 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: CAPLYTA, COBENFY, LYBALVI, ARISTADA, REXULTI, INGREZZA, INVEGA SUSTENNA, FANAPT.
Industry payments across FL — which companies pay providers there.
